EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

DYNC1H1 in Spinal Muscular Atrophy: Diagnostic Findings From Two Families and a Comprehensive Review of Its Role in Neuromuscular and Neurodevelopmental Disorders

Maryam Namdari, Behnaz Ansari, Keivan Basiri, Elham Sadat Azimi, Majid Hosseinzadeh, Amir Bahreini, Narges Nouri, Maryam Sedghi, Shirin Fattahpur, Mahsa M Amoli iD, Homa Tajsharghi iD

Molecular Genetics & Genomic Medicine · 2025

DOI: 10.1002/mgg3.70163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Maryam Namdari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Laboratory, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Cytoplasmic Dyneins, Muscular Atrophy, Spinal, Neurodevelopmental Disorders. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The European Union's Seventh Framework Program for research, technological development and demonstration, EU-Mobility for Regional Excellence (MoRE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

DYNC1H1 is a critical gene implicated in neurodevelopmental and neuromuscular disorders with overlapping and variable phenotypes that challenge diagnosis. Methods and Results Whole exome sequencing in patients presenting with motor neuron disease symptoms and a predominant pattern of lower‐limb muscle weakness revealed pathogenic DYNC1H1 variants. This expands the known phenotypic spectrum to include rare features such as scapular winging and camptocormia. Clinical evaluations of affected individuals revealed features consistent with SMA‐LED, reinforcing the role of DYNC1H1 in neuromuscular disorders. A review of 208 published DYNC1H1 variants highlighted significant clustering in the tail domain, primarily associated with neuromuscular conditions like SMA‐LED. Approximately 28% of variants exhibited overlapping neuromuscular and neurodevelopmental features, emphasizing the diagnostic challenges posed by phenotypic overlap. These findings underscore the necessity of comprehensive clinical and genetic evaluations to address the variability observed within families and improve genotype–phenotype correlations.

Conclusion

This study reinforces the importance of DYNC1H1 in motor neuron function and its pivotal role in neurodevelopmental and neuromuscular disease mechanisms. The integration of exome sequencing in clinical practice is essential for identifying rare and novel variants, enhancing diagnostic accuracy. We recommend incorporating DYNC1H1 screening into diagnostic workflows to advance understanding and management of conditions with overlapping phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytoplasmic DyneinsMuscular Atrophy, SpinalNeurodevelopmental DisordersAdolescentAdultChildChild, PreschoolFemaleHumansMaleMutationNeuromuscular DiseasesPedigreePhenotype

Substanzen

Cytoplasmic DyneinsDYNC1H1 protein, human

Autor:innen und Institutionen

  • Medical Genetics Laboratory, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Neurology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Karyogen Medical Genetics Laboratory, Isfahan, Iran.
  • Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mahsa M Amoli, Homa Tajsharghi

Förderung

  • The European Union's Seventh Framework Program for research, technological development and demonstration
  • EU-Mobility for Regional Excellence (MoRE)

Zitieren

APA

Namdari, M., Ansari, B., Basiri, K., Azimi, E. S., Hosseinzadeh, M., Bahreini, A., Nouri, N., Sedghi, M., Fattahpur, S., Amoli, M. M., & Tajsharghi, H. (2025). DYNC1H1 in Spinal Muscular Atrophy: Diagnostic Findings From Two Families and a Comprehensive Review of Its Role in Neuromuscular and Neurodevelopmental Disorders. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70163

Vancouver

Namdari M, Ansari B, Basiri K, Azimi ES, Hosseinzadeh M, Bahreini A, et al. DYNC1H1 in Spinal Muscular Atrophy: Diagnostic Findings From Two Families and a Comprehensive Review of Its Role in Neuromuscular and Neurodevelopmental Disorders. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70163

BibTeX
@article{Namdari2025,
  author = {Namdari, Maryam and Ansari, Behnaz and Basiri, Keivan and Azimi, Elham Sadat and Hosseinzadeh, Majid and Bahreini, Amir and Nouri, Narges and Sedghi, Maryam and Fattahpur, Shirin and Amoli, Mahsa M and Tajsharghi, Homa},
  title = {DYNC1H1 in Spinal Muscular Atrophy: Diagnostic Findings From Two Families and a Comprehensive Review of Its Role in Neuromuscular and Neurodevelopmental Disorders},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2025},
  doi = {10.1002/mgg3.70163}
}
Kostenlos starten →